In this study, we induced CNV in rabbits and measured VEGF-A levels and AH viscosity. We found that eyes with induced CNV had higher AH viscosity than control eyes, and viscosity strongly correlated with VEGF-A concentration in eyes with induced CNV. To the best of our knowledge, this is the first study to investigate the relationship between the AH viscosity and VEGF-A levels in eyes with neovascularization. Our findings provide significant insights into the role of AH viscosity in IOP elevation in ocular conditions with elevated VEGF-A levels, such as NVG, and its impact on surgical outcomes.
Research on the AH viscosity is sparse,
23,29–31 and most existing studies have focused on the composition and flow dynamics of AH rather than its viscosity. In the context of NVG, several studies have reported elevated levels of various growth factors, including VEGF-A, and inflammatory cytokines in the AH.
4,5,32 These factors are implicated in the promotion of angiogenesis and the exacerbation of inflammation, thereby contributing to NVG pathogenesis. However, few studies have explored how these components influence AH viscosity and consequently affect outflow resistance and IOP. The primary advantage of this study lies in its detailed examination of AH viscosity in the context of neovascularization.
To ensure the reliability of our viscosity measurements, we first confirmed the relationship between protein concentration and viscosity using BSA solutions. Our results show a clear concentration-dependent increase in viscosity,
33,34 which validated the precision and accuracy of our viscometer and ensured the reliability of the AH viscosity measurements in the rabbit CNV model. Our animal experiments further revealed that VEGF-A concentrations were significantly higher in CNV-treated eyes than in sham-induced or naïve eyes. This elevation in VEGF-A levels was accompanied by a marked increase in AH viscosity. These findings suggest that VEGF-A not only contributes to neovascularization, but also affects the physical properties of the AH, such as viscosity. The strong positive correlation (
P < 0.02,
r = 1.00) observed in our CNV-induced model underscores the potential of AH viscosity as a biomarker of NVG disease severity and prognosis.
Increased AH viscosity has significant clinical implications in glaucoma surgery. Surgical interventions for NVG, such as trabeculectomy and aqueous shunt implantation, rely on the efficient outflow of the AH through surgical channels or drainage devices to control IOP.
1,35 Although we did not directly measure changes in IOP according to AH viscosity, our findings suggest that increased AH viscosity in the NVG might influence the resistance to AH outflow, which is critical for the success of these surgical procedures. If future research confirms that AH viscosity affects outflow resistance, AH viscosity could be considered in the preoperative evaluation and surgical planning of patients with NVG. In addition, it may be necessary to modify surgical techniques or develop new devices that can better accommodate variations in the AH viscosity. For instance, adjusting the diameter or material of the shunt devices to optimize the flow dynamics in the context of altered viscosity should be considered in future studies.
In this study, we observed a significant correlation between AH viscosity and VEGF-A concentration, similar to that observed for total protein concentration. These findings suggest that elevated VEGF-A levels observed in the CNV-induced model may have contributed to increased vascular permeability, leading to a concurrent increase in total protein levels. This is consistent with the findings of a previous study that reported a positive correlation between VEGF-A and total protein concentrations in the aqueous humor of patients with NVG.
36 This raises the possibility that the increase in AH viscosity observed in our study could be influenced not solely by VEGF-A levels, but also by the associated elevation in total protein concentration. However, it is important to note that under neovascular conditions, not all proteins are equally elevated, nor do they contribute uniformly to viscosity changes. Thus VEGF-A, a pivotal mediator of NVG pathophysiology, may serve as a potential marker of viscosity-related alterations that affect AH outflow. Future studies analyzing the relationship between the total protein concentration and viscosity following anti-VEGF-A therapy in neovascular conditions could provide valuable insights into the direct impact of VEGF-A on AH viscosity.
This study had several limitations that should be noted when interpreting our findings. First, although the CNV model effectively induced elevated VEGF-A levels and allowed us to investigate its relationship with AH viscosity, it did not fully replicate the extensive neovascularization and pathophysiology observed in NVG. Unlike NVG that involves widespread neovascularization of the iris and anterior chamber angle and leads to pronounced IOP elevation, the CNV model provides a localized response. Additionally, we did not measure the corresponding changes in IOP, as the severe corneal alkaline burns used in the model made accurate IOP measurements through corneal contact challenging. Despite these limitations, the CNV model serves as a practical and reproducible system for isolating and studying VEGF-A-induced changes in AH viscosity. Future studies should address these gaps by using more advanced models that better replicate the multifactorial nature of NVG, including its effects on IOP. Second, the sample size was relatively small, with only 10 rabbits used in this study. Larger studies with other animal models and potentially human clinical studies are needed to confirm these findings and explore the variability in AH viscosity among a broader population. Third, although the correlation between VEGF-A and AH viscosity is evident, its potential impact on surgical outcomes, specifically in the context of glaucoma shunt surgery, requires further investigation. Future studies should evaluate the surgical outcomes in patients with varying AH viscosity levels, particularly in those undergoing shunt surgeries. Analyzing postoperative outcomes and complications in these patients could provide valuable insights into the role of AH viscosity in surgical prognosis.
In conclusion, this study highlights the significant correlation between the VEGF-A concentration and AH viscosity in a CNV-induced rabbit model. These findings suggest that NVG, which is characterized by uncontrolled IOP and poor surgical outcomes, may be associated not only with elevated VEGF-A levels in the AH, but also with increased AH viscosity. Further research is required to determine the effect of AH viscosity on aqueous outflow resistance and IOP elevation in all forms of glaucoma.